|
pubmed:abstractText |
The presence of anemia before percutaneous coronary intervention (PCI) and/or the development of bleeding or anemia after PCI has been shown to increase mortality and morbidity rates. However, the definition of severe anemia varies among reports. In this context, the roles of hematocrit at baseline and hematocrit drop after PCI, both treated as continuous variables, have not yet been described in the risk assessment of patients undergoing PCI.
|
|
pubmed:affiliation |
Division of Cardiology, Department of Internal Medicine, Washington Hospital Center, Washington, DC 20010, USA.
|
